Submit Deal

ALLAY THERAPEUTICS

HQ - San Jose, CA

Summary

Allay Therapeutics is a clinical-stage biotechnology company developing ultra-sustained analgesic products to transform post-surgical pain management and recuperation.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 42 M

Avg. Deal Size£ 42 M

Market Context

Senior Management

Adam Gridley
President and CEO

Sort

05 Jun 2025|United States|Health Care Services

Target: ALLAY THERAPEUTICS

Bidder: LIGHTSTONE VENTURES

4 Service Providers

1 Target | 3 Bidder

6 Dealmakers

1 Target | 5 Bidder

£ 42 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy